반응형

62366 5

[Emergo, UL] Substituting proxy participants for actual intended users in human factors validation testing

Including representative and intended users for a human factors (HF) validation test provides invaluable data for manufacturers because participants’ performance data can demonstrate a product’s expected safety and effectiveness once it is in the market. However, it can also be extremely difficult, or nearly impossible, to recruit exact users for a particular product due to the rarity of a condi..

뉴스 보고서 2025.05.09

[Emergo, UL] The Benefits of Running Pilot Tests for Usability Studies

Why pilot tests are essential for usability studiesDeveloping a methodology for usability studies can involve uncertainty and introduce questions such as “How long should the test session last?,” “How can I improve my setup?” or “Is this prompt clear enough?” Running pilot test sessions prior to formal testing can help you find answers to these questions and increase the data quality of your upc..

뉴스 보고서 2025.02.07

[Emergo, UL] How to Conduct a Known Problems Analysis (KPA) for NMPA Compliance

Why a known problems analysis is crucial for NMPA complianceA known problems analysis (KPA) is a human factors engineering (HFE) activity that aims to identify use issues and user interface flaws with devices currently on the market. Regulators require medical device manufacturers to conduct a KPA to investigate use problems associated with devices that are similar to a device under development ..

뉴스 보고서 2025.02.06

[Emergo, UL] What Does it Mean for a Device to be Inherently Safe by Design?

Both the FDA’s Human Factors Engineering (HFE) guidance and the global HFE standard IEC-62366 list “inherent safety by design” as the most effective method of managing use-related risks associated with medical devices. In this article, we discuss what is meant by safety by design, provide examples of products that demonstrate it and explore how it can be implemented within medical device design...

뉴스 보고서 2024.12.18
반응형